Assenagon Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-384,002
Closed -$5.9M 1603
2021
Q4
$5.9M Buy
+384,002
New +$5.05M 0.02% 468
2020
Q4
Sell
-33,633
Closed -$205K 1318
2020
Q3
$205K Buy
+33,633
New +$257K ﹤0.01% 1071
2020
Q2
Sell
-67,500
Closed -$489K 1281
2020
Q1
$489K Buy
+67,500
New +$500K ﹤0.01% 646
2019
Q4
Sell
-288,980
Closed -$1.76M 992
2019
Q3
$1.76M Buy
+288,980
New +$1.62M 0.01% 436
2019
Q1
Sell
-95,876
Closed -$621K 1166
2018
Q4
$621K Buy
+95,876
New +$733K 0.01% 774

Other funds holding NPTN

Assenagon Asset Management's NPTN Position: Q1 2022 in Review

Assenagon Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 384,002 shares — an estimated $5.9M sold.

Assenagon Asset Management first reported a position in NPTN in Q4 2018 and held it in 5 quarters. The position peaked at $5.9M in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Assenagon Asset Management reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 384,002 NEOPHOTONICS CORP shares in Q1 2022, an estimated $5.9M.
  • Assenagon Asset Management first reported a position in NEOPHOTONICS CORP in Q4 2018 and held it in 5 quarters.
  • Assenagon Asset Management's NEOPHOTONICS CORP position peaked at $5.9M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.